Game-Changing Treatment for T1D Enters Clinical Trials
Read ArticleBlog Posts focused on: Sound Life Project (SLP); Type 1 Diabetes (T1D); Biorepository
Innovation Fund Spotlight: Pioneering a New Generation of Tetramers
In the late 1990s, Bill Kwok, PhD, pioneered MHC class II tetramers, a game-changing tool in immunology research. Tetramers have fueled countless research breakthroughs because they enable scientists to find extremely rare cells and extract them to study in precise detail.
New Technology Opens the Door to Understanding the Earliest Stages of T1D
Eddie James, PhD, earned a new grant to explore early cell changes that lead to T1D, using a new tool pioneered at BRI.
Eddie Irvine, PhD, Uses Engineering and AI to Explore Big Questions in Immunology
Eddie Irvine, PhD, recently joined BRI as a Principal Investigator in the Center for Systems Immunology. He’ll use his unique background in protein engineering and AI to better understand the immune system and find new ways to treat disease.
How Does Wildfire Smoke Impact the Immune System?
As wildfire smoke becomes more common in the Pacific Northwest, BRI scientists are learning more about how it influences immune system function. We asked Dr. Megan Smithmyer about her research in this area and a new study examining the immune systems of wildland firefighters.
Could GLP-1RA Medications Help Treat Type 1 Diabetes?
Sarah Kobernat, PhD, is working to find out.
Behind BRI's Biorepositories: How they started and continue to fuel discoveries
Learn how our biorepositories power life-changing breakthroughs.
Remembering Becky Benaroya: A Legacy of Generosity and Support for Science
Benaroya Research Institute honors and remembers (“Becky”) Benaroya, a beloved member of our community whose generosity, compassion and commitment to improving lives leaves a remarkable impact.
Weathering Uncertainty with Resilience
Read recent highlights and learn what’s on the horizon in 2026 from BRI President Jane Buckner, MD.
A Decades-Long Dream Becomes Reality
Learn how research led by Jane Buckner, MD, is bringing regulatory T cell-based therapies closer to clinical trials.
Innovation Fund Spotlight: Exploring Immune System Cells and Gut Bacteria
Allyson Byrd, PhD, is an expert in the gut microbiome, the study of the tiny organisms that live inside our digestive system. James Lord, MD, PhD, is a gastroenterologist who has studied inflammatory bowel diseases (IBD) like Crohn’s disease and ulcerative colitis for more than 20 years.